UMB Bank’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.51K Buy
583
+63
+12% +$608 ﹤0.01% 1978
2026
Q1
$3.86K Sell
520
-145
-22% -$1.53K ﹤0.01% 2075
2025
Q4
$7.82K Buy
665
+169
+34% +$1.82K ﹤0.01% 1904
2025
Q3
$3.83K Buy
496
+90
+22% +$630 ﹤0.01% 1944
2025
Q2
$2.97K Buy
+406
New +$3.28K ﹤0.01% 1944
2025
Q1
Sell
-293
Closed -$4.83K 2148
2024
Q4
$4.83K Buy
293
+7
+2% +$109 ﹤0.01% 1721
2024
Q3
$4.22K Buy
286
+179
+167% +$2.8K ﹤0.01% 1783
2024
Q2
$1.48K Buy
107
+51
+91% +$723 ﹤0.01% 1872
2024
Q1
$880 Buy
+56
New +$865 ﹤0.01% 1823

Other funds holding NEO

UMB Bank's NEO Position: Q2 2026 in Review

UMB Bank increased its NeoGenomics (NEO) stake by 12% in Q2 2026, buying an estimated $608 and bringing the position to 583 shares worth $8.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

UMB Bank first reported a position in NEO in Q1 2024 and has held it in 9 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • UMB Bank held 583 shares of NeoGenomics worth $8.51K as of Q2 2026.
  • UMB Bank bought 63 NeoGenomics shares in Q2 2026, an estimated $608.
  • NeoGenomics made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1978 holding.
  • UMB Bank first reported a position in NeoGenomics in Q1 2024 and has held it in 9 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.